Inactive Instrument

Press Releases Marizyme, Inc. Other OTC

Equities

GBSX

US5703721028

Press Releases

Unlock all the news: Be the first to know and act before the market!

Marizyme : Secures FDA 510(k) Clearance for Controlled Room Temperature storage DuraGraft® - Form 8-K	05-06	PU
Marizyme, Inc. Secures FDA 510(k) Clearance for Controlled Room Temperature Storage DuraGraft	05-06	AQ
Marizyme Enters Into Co-Development Agreement With Qualigen Therapeutics for the Commercialization of FDA-Cleared DuraGraft™	04-16	GL
Marizyme CEO Delivers Business Update	23/10/23	EQ
Marizyme CEO Delivers Business Update	23/10/23	GL
OTC Active Stocks Watchlist (EPAZ, MRZM, GCEI, TMGI)	09/10/23	AQ
Marizyme, Inc. Announces FDA Clearance for Flagship Product, DuraGraft™	06/10/23	GL
MARIZYME, INC. : Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	24/05/23	AQ
MARIZYME INC : Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	10/05/23	AQ
Marizyme Announces IP Developments for DuraGraft® and Its Pipeline Products	10/05/23	GL
Marizyme Announces IP Developments for DuraGraft® and Its Pipeline Products	10/05/23	AQ
Marizyme CEO Delivers Business Update	03/05/23	GL
MARIZYME INC Submission of Matters to a Vote of Security Holders (form 8-K/A)	26/04/23	AQ
MARIZYME INC : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	20/04/23	AQ
MARIZYME INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	24/03/23	AQ
MARIZYME INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	07/02/23	AQ
MARIZYME INC : Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	17/01/23	AQ
MARIZYME INC : Material Modification to Rights of Security Holders, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	05/01/23	AQ
MARIZYME INC : Submission of Matters to a Vote of Security Holders (form 8-K)	28/12/22	AQ
MARIZYME INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	14/11/22	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Marizyme, Inc. Other OTC

Equities

GBSX

US5703721028

Press Releases

Filters